Monocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Tong, Jing ^a,b   Buch, Shilpa ^c   Yao, Honghong ^c   Wu, Chengxiang ^b   Tong, Hsin I ^b   Wang, Youwei ^a   Lu, Yuanan ^b  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; RETROVIRUS VECTOR; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOTOXICITY TEST; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TRANSFER; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MONOCYTE; MOUSE; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIMARY CELL CULTURE; PROTEIN SECRETION; PROTEIN STABILITY; STABLE EXPRESSION; TRANSIENT TRANSFECTION; WESTERN BLOTTING;

AIDS DEMENTIA COMPLEX; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENE EXPRESSION; HUMANS; LENTIVIRUS; MACROPHAGES; MALE; MICE; MONOCYTES; TRANSDUCTION, GENETIC;

EID: 84895525206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082030     Document Type: Article

References (65)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799. (Pubitemid 350059308)
2. Ghafouri M, Amini S, Khalili K, Sawaya BE (2006) HIV-1 associated dementia: symptoms and causes. Retrovirology 3: 28.
3. Boisse L, Gill MJ, Power C (2008) HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin 26: 799-819. (Pubitemid 352037443)
4. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, et al. (1999) Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. Aids 13: 1249-1253. (Pubitemid 29361096)
5. Foley J, Ettenhofer M, Wright M, Hinkin CH (2008) Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep 5: 204-211.
6. Major EO, Rausch D, Marra C, Clifford D (2000) HIV-associated dementia. Science 288: 440-442.
7. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P (2011) HIV-1 infection and cognitive impairment in the cART era: a review. Aids 25: 561-575.
8. Thomas SA (2004) Anti-HIV drug distribution to the central nervous system. Curr Pharm Des 10: 1313-1324.
9. Liner KJ 2nd, Hall CD, Robertson KR (2008) Effects of antiretroviral therapy on cognitive impairment. Curr HIV/AIDS Rep 5: 64-71. (Pubitemid 351656419)
10. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA (2005) HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death and Differentiation 12: 878-892. (Pubitemid 41038393)
11. Asahchop EL, Wainberg MA, Sloan RD, Tremblay CL (2012) Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors. Antimicrob Agents Chemother.
12. Barbacid M (1995) Neurotrophic Factors and Their Receptors. Current Opinion in Cell Biology 7: 148-155.
13. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237: 1154-1162.
14. Segal RA, Greenberg ME (1996) Intracellular signaling pathways activated by neurotrophic factors. Annual Review of Neuroscience 19: 463-489. (Pubitemid 26080836)
15. Rauskolb S, Zagrebelsky M, Dreznjak A, Deogracias R, Matsumoto T, et al. (2010) Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J Neurosci 30: 1739-1749.
16. Connor B, Dragunow M (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Research Reviews 27: 1-39. (Pubitemid 28300281)
17. Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Progress in Neurobiology 63: 71-124.
18. Dou H, Kingsley JD, Mosley RL, Gelbard HA, Gendelman HE (2004) Neuroprotective strategies for HIV-1 associated dementia. Neurotox Res 6: 503-521.
19. Nosheny RL, Mocchetti I, Bachis A (2005) Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotoxicity Research 8: 187-198.
20. Avdoshina V, Garzino-Demo A, Bachis A, Monaco MC, Maki PM, et al. (2011) HIV-1 decreases the levels of neurotrophins in human lymphocytes. Aids 25: 1126-1128.
21. Mocchetti I, Bachis A (2004) Brain-derived neurotrophic factor activation of TrkB protects neurons from HIV-1/gp120-induced cell death. Crit Rev Neurobiol 16: 51-57. (Pubitemid 39586902)
22. Mocchetti I, Nosheny RL, Tanda G, Ren K, Meyer EM (2007) Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system. Neuroprotective Agents: Eighth International Neuroprotection Society Meeting 1122: 144-154.
23. Nosheny RL, Ahmed F, Yakovlev A, Meyer EM, Ren K, et al. (2007) Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo. European Journal of Neuroscience 25: 2275-2284. (Pubitemid 46625935)
24. Nosheny RL, Bachis A, Acquas E, Mocchetti I (2004) Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. European Journal of Neuroscience 20: 2857-2864. (Pubitemid 40007279)
25. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755-762.
26. Bart J, Groen HJ, Hendrikse NH, van der Graaf WT, Vaalburg W, et al. (2000) The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treat Rev 26: 449-462. (Pubitemid 32094862)
27. Gras G, Kaul M (2010) Molecular mechanisms of neuroinvasion by monocytesmacrophages in HIV-1 infection. Retrovirology 7: 30.
28. Boehme SA, Lio FM, Maciejewski-Lenoir D, Bacon KB, Conlon PJ (2000) The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 165: 397-403. (Pubitemid 30429532)
29. Burke B (2003) Macrophages as novel cellular vehicles for gene therapy. Expert Opin Biol Ther 3: 919-924.
30. Dou H, Grotepas CB, McMillan JM, Destache CJ, Chaubal M, et al. (2009) Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol 183: 661-669.
31. Wu J, Yang S, Luo H, Zeng L, Ye L, et al. (2006) Quantitative evaluation of monocyte transmigration into the brain following chemical opening of the blood-brain barrier in mice. Brain Res 1098: 79-85. (Pubitemid 44277988)
32. Zeng L, Yang S, Wu C, Ye L, Lu Y (2006) Effective transduction of primary mouse blood- and bone marrow-derived monocytes/macrophages by HIV-based defective lentiviral vectors. J Virol Methods 134: 66-73.
33. Lundberg C, Bjorklund T, Carlsson T, Jakobsson J, Hantraye P, et al. (2008) Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Curr Gene Ther 8: 461-473.
34. Lim ST, Airavaara M, Harvey BK (2010) Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol Res 61: 14-26.
35. Uchida N, Sutton RE, Friera AM, He D, Reitsma MJ, et al. (1998) HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc Natl Acad Sci U S A 95: 11939-11944. (Pubitemid 28460518)
36. Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T (2000) IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1: 376-382.
37. Nicolini A, Ajmone-Cat MA, Bernardo A, Levi G, Minghetti L (2001) Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-kappaB activation and oxidative stress in microglial cultures by independent mechanisms. J Neurochem 79: 713-716. (Pubitemid 33029944)
38. Yeung MC, Pulliam L, Lau AS (1995) The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. Aids 9:137-143.
39. Buscemi L, Ramonet D, Geiger JD (2007) Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Neurobiol Dis 26: 661-670. (Pubitemid 46756331)
40. Zeng L, Planelles V, Sui Z, Gartner S, Maggirwar SB, et al. (2006) HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1. J Gene Med 8: 18-28. (Pubitemid 43169377)
41. Alexaki A, Wigdahl B (2008) HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog 4: e1000215.
42. Clay CC, Rodrigues DS, Ho YS, Fallert BA, Janatpour K, et al. (2007) Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. J Virol 81: 12040-12048. (Pubitemid 47623834)
43. Gartner S (2000) HIV infection and dementia. Science 287: 602-604.48.
44. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, et al. (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089-1093.
45. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, et al. (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093. (Pubitemid 16032241)
46. Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994. (Pubitemid 32335850)
47. Bachis A, Mocchetti I (2005) Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins. Ann N Y Acad Sci 1053: 247-257. (Pubitemid 43031104)
48. Mocchetti I, Nosheny RL, Tanda G, Ren K, Meyer EM (2007) Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system. Ann N Y Acad Sci 1122: 144-154. (Pubitemid 350249545)
49. Nosheny RL, Ahmed F, Yakovlev A, Meyer EM, Ren K, et al. (2007) Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo. Eur J Neurosci 25: 2275-2284. (Pubitemid 46625935)
50. Nosheny RL, Mocchetti I, Bachis A (2005) Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotox Res 8: 187-198.
51. Nosheny RL, Bachis A, Acquas E, Mocchetti I (2004) Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. Eur J Neurosci 20: 2857-2864. (Pubitemid 40007279)
52. Nosheny RL, Bachis A, Aden SA, De Bernardi MA, Mocchetti I (2006) Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. J Neurobiol 66: 1311-1321. (Pubitemid 44713810)
53. Meeker RB, Poulton W, Markovic-Plese S, Hall C, Robertson K (2011) Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection. J Neurovirol 17: 258-273.
54. Shoichet MS, Winn SR (2000) Cell delivery to the central nervous system. Adv Drug Deliv Rev 42: 81-102. (Pubitemid 30609636)
55. Batrakova EV, Gendelman HE, Kabanov AV (2011) Cell-mediated drug delivery. Expert Opin Drug Deliv 8: 415-433.
56. McMillan J, Batrakova E, Gendelman HE (2011) Cell delivery of therapeutic nanoparticles. Prog Mol Biol Transl Sci 104: 563-601.
57. Biju K, Zhou Q, Li G, Imam SZ, Roberts JL, et al. (2010) Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease. Mol Ther 18: 1536-1544.
58. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, et al. (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-823.
59. Rai AJ, Kamath RM, Gerald W, Fleisher M (2009) Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling. Anal Bioanal Chem 393: 1505-1511.
60. Li J, Mao NY, Zhang C, Yang MJ, Wang M, et al. (2012) The development of a GeXP-based multiplex reverse transcription-PCR assay for simultaneous detection of sixteen human respiratory virus types/subtypes. BMC Infect Dis 12: 189.
61. Farquharson AJ, Steele RJ, Carey FA, Drew JE (2012) Novel multiplex method to assess insulin, leptin and adiponectin regulation of inflammatory cytokines associated with colon cancer. Mol Biol Rep 39: 5727-5736.
62. Kida K, Kobayashi K, Kimura H, Yugari Y (1973) Glycerokinase in rat liver. I. The effect of fat and its components on glycerokinase activity in rat liver. J Biochem 73: 299-306.
63. Cao SB, Wu XC, Yang YB, Sniderhan LF, Maggirwar S, et al. (2011) Lentiviral vector-mediated expression of sTNFR-Fc in stably transduced human macrophage and neuronal cells: implications for NeuroAIDS therapeutic. J. Neuroinflammation 8: 48-58.
64. Wu C, Lu Y (2010) High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages. J Gen Virol 91:1909-1918.
65. Wu C, Lu Y (2007) Inclusion of high molecular weight dextran in calcium phosphate-mediated transfection significantly improves gene transfer efficiency. Cell Mol Biol (Noisy-le-grand) 53:67-74. (Pubitemid 47451195)